Literature DB >> 8458434

Isolation of a novel substrate-competitive tyrosine kinase inhibitor, desmal, from the plant Desmos chinensis.

H Kakeya1, M Imoto, Y Tabata, J Iwami, H Matsumoto, K Nakamura, T Koyano, K Tadano, K Umezawa.   

Abstract

In the course of a screening program for tyrosine kinase inhibitors, the chloroform extract of a tropical plant, Desmos chinensis, strongly inhibited the enzyme activity. The active substance was purified by silica gel, gel filtration, and finally crystallized. The structure was elucidated by mass spectrometry and X-ray crystallography to be 8-formyl-2,5,7-trihydroxy-6- methylflavanone, and we named it desmal. Desmal competed with peptide substrate and non-competed with ATP. It inhibited tyrosine kinase in situ in epidermal growth factor (EGF) receptor-overexpressing NIH3T3 (ER12) cells. It also inhibited EGF-induced inositol phosphate formation and morphological changes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8458434     DOI: 10.1016/0014-5793(93)80085-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  Mass spectrometric characterization of a series of adenosylated peptides acting as bisubstrate analogs of protein kinases.

Authors:  B W Gibson; D Medzihradszky; W M Hines; S Auriola; G L Kenyon
Journal:  J Am Soc Mass Spectrom       Date:  1994-05       Impact factor: 3.109

2.  α-Glucosidase inhibitory activity of compounds isolated from the twig and leaf extracts of Desmos dumosus.

Authors:  Virayu Suthiphasilp; Tharakorn Maneerat; Raymond J Andersen; Brian O Patrick; Stephen G Pyne; Surat Laphookhieo
Journal:  Heliyon       Date:  2021-02-15

3.  Desmoschinensisflavones A and B, two rare flavones having a hybrid benzyl benzoate ester-flavone structural framework from Desmos chinensis Lour.

Authors:  Isaraporn Polbuppha; Virayu Suthiphasilp; Tharakorn Maneerat; Rawiwan Charoensup; Thunwadee Limtharakul; Sarot Cheenpracha; Stephen G Pyne; Surat Laphookhieo
Journal:  RSC Adv       Date:  2020-12-21       Impact factor: 3.361

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.